|
[1]
|
Links of platelet glutamate and glutathione metabolism with attenuated positive and negative symptoms in depressed patients at clinical high risk for psychosis
European Archives of Psychiatry and Clinical Neuroscience,
2023
DOI:10.1007/s00406-022-01396-7
|
|
|
|
|
[2]
|
Correlations between biochemical and clinical parameters in patients at risk for schizophrenia spectrum disorders
Vestnik nevrologii, psihiatrii i nejrohirurgii (Bulletin of Neurology, Psychiatry and Neurosurgery),
2023
DOI:10.33920/med-01-2303-06
|
|
|
|
|
[3]
|
The Relationship between Treatment Response in Patients with Acute Psychotic Episodes of Schizophrenia and the Activity of Their Platelet Enzymes
Psikhiatriya,
2023
DOI:10.30629/2618-6667-2023-21-4-16-26
|
|
|
|
|
[4]
|
Anomalies of Energy Metabolism in Schizophrenia and Possible Pathogenetically Targeted Therapeutic Approaches
Neurochemical Journal,
2023
DOI:10.1134/S1819712423040086
|
|
|
|
|
[5]
|
Links of platelet glutamate and glutathione metabolism with attenuated positive and negative symptoms in depressed patients at clinical high risk for psychosis
European Archives of Psychiatry and Clinical Neuroscience,
2022
DOI:10.1007/s00406-022-01396-7
|
|
|
|
|
[6]
|
Activity of enzymes of glutamate, energy and glutathione metabolism in the first juvenile depression with attenuated symptoms of schizophrenia
Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova,
2022
DOI:10.17116/jnevro2022122081136
|
|
|
|
|
[7]
|
The link of platelet cytochrome C-oxidase activity with some clinical parameters of depression in elderly patients
Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova,
2021
DOI:10.17116/jnevro202112103186
|
|
|
|
|
[8]
|
The use of antioxidant medicine as an adjunctive therapy in late-onset schizophrenia spectrum disorders
Neurology Bulletin,
2021
DOI:10.17816/nb87427
|
|
|
|
|
[9]
|
Decrease in 130 kDa- amyloid protein precursor protein (APP) and APP protein ratio in schizophrenia platelets
Neuroscience Letters,
2020
DOI:10.1016/j.neulet.2020.134914
|
|
|
|